Old Web
English
Sign In
Acemap
>
Paper
>
Phase II study of imatinib mesylate (ST1571) for patients with recurrent meningiomas (NABTC 01-08)
Phase II study of imatinib mesylate (ST1571) for patients with recurrent meningiomas (NABTC 01-08)
2006
Patrick Y. Wen
W. A. Yung
Kathleen R. Lamborn
Timothy F. Cloughesy
L. M. DeAngelis
Howard A. Fine
S. M. Chang
H. I. Robins
Karen Fink
Lauren E. Abrey
Andrew B. Lassman
M.P. Mehta
Santosh Kesari
Lyndon Kim
Charles D. Stiles
Merrill J. Egorin
Richard S. Kaplan
Anthony J. Murgo
Prados
Keywords:
Phases of clinical research
Mesylate
Cancer research
Psychiatry
Imatinib
Medicine
Internal medicine
imatinib mesylate
Oncology
clinical neurology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
13
Citations
NaN
KQI
[]